VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 9 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2012. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,937,000 | +39.1% | 83,328 | -4.8% | 0.02% | +30.8% |
| Q1 2018 | $1,393,000 | +10.7% | 87,513 | +44.5% | 0.01% | +18.2% |
| Q4 2017 | $1,258,000 | -20.6% | 60,557 | -45.4% | 0.01% | -26.7% |
| Q3 2017 | $1,585,000 | -17.6% | 110,880 | 0.0% | 0.02% | -21.1% |
| Q2 2017 | $1,924,000 | +66.6% | 110,880 | +5.8% | 0.02% | +72.7% |
| Q1 2017 | $1,155,000 | -28.0% | 104,826 | -5.2% | 0.01% | -35.3% |
| Q4 2016 | $1,605,000 | -23.0% | 110,574 | +30.0% | 0.02% | -22.7% |
| Q3 2016 | $2,084,000 | +41.7% | 85,078 | +16.0% | 0.02% | +15.8% |
| Q2 2016 | $1,471,000 | -23.8% | 73,340 | 0.0% | 0.02% | -20.8% |
| Q1 2016 | $1,931,000 | -73.2% | 73,340 | +3.2% | 0.02% | -73.6% |
| Q4 2015 | $7,193,000 | -21.7% | 71,082 | +37.5% | 0.09% | -30.0% |
| Q3 2015 | $9,187,000 | +0.7% | 51,709 | +25.8% | 0.13% | +3.2% |
| Q2 2015 | $9,123,000 | +6.4% | 41,110 | -5.3% | 0.13% | +5.9% |
| Q1 2015 | $8,576,000 | +114.7% | 43,411 | +53.5% | 0.12% | -3.3% |
| Q4 2014 | $3,994,000 | -1.2% | 28,283 | -16.5% | 0.12% | -7.5% |
| Q3 2014 | $4,044,000 | -6.1% | 33,879 | -21.2% | 0.13% | +4.7% |
| Q2 2014 | $4,305,000 | +1.6% | 42,977 | +4.7% | 0.13% | -3.1% |
| Q1 2014 | $4,238,000 | +8.2% | 41,041 | -2.7% | 0.13% | +2.3% |
| Q4 2013 | $3,917,000 | +12.1% | 42,171 | +3.4% | 0.13% | +5.8% |
| Q3 2013 | $3,493,000 | +36.6% | 40,784 | +22.6% | 0.12% | +36.0% |
| Q2 2013 | $2,557,000 | +19.3% | 33,255 | +16.5% | 0.09% | +18.7% |
| Q1 2013 | $2,143,000 | +56.8% | 28,545 | +24.5% | 0.08% | +38.9% |
| Q4 2012 | $1,367,000 | +16.3% | 22,936 | +7.6% | 0.05% | +12.5% |
| Q3 2012 | $1,175,000 | +37.3% | 21,308 | +11.5% | 0.05% | +26.3% |
| Q2 2012 | $856,000 | +24.2% | 19,118 | +48.5% | 0.04% | +22.6% |
| Q1 2012 | $689,000 | +17.6% | 12,878 | +2.8% | 0.03% | +14.8% |
| Q4 2011 | $586,000 | – | 12,527 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |